X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

HOUSTON-The local Texas Heart Institute has teamed with Texas A&M University of College of Veterinary Medicine and Biomedical Sciences in College Station, TX, to create the Center for Cell and Organ Biotechnology. The center will be located in Houston, and is being funded, in part, by the State of Texas’ Emerging Technology Fund to the tune of $3 million.

The new center will be led by Doris Taylor, director of regenerative medicine research at THI. The new center will take a multi-faceted approach to chronic disease for both human and veterinary health care, based on cell and organ failure and will include scientists, engineers, physicians, veterinarians and business managers from both THI and Texas A&M.

Want to continue reading?
Become a Free ALM Digital Reader.

Once you are an ALM digital member, you’ll receive:

  • Unlimited access to GlobeSt and other free ALM publications
  • Access to 15 years of GlobeSt archives
  • Your choice of GlobeSt digital newsletters and over 70 others from popular sister publications
  • 1 free article* every 30 days across the ALM subscription network
  • Exclusive discounts on ALM events and publications

*May exclude premium content
Already have an account?

Dig Deeper

GlobeSt

Join GlobeSt

Don't miss crucial news and insights you need to make informed commercial real estate decisions. Join GlobeSt.com now!

  • Free unlimited access to GlobeSt.com's trusted and independent team of experts who provide commercial real estate owners, investors, developers, brokers and finance professionals with comprehensive coverage, analysis and best practices necessary to innovate and build business.
  • Exclusive discounts on ALM and GlobeSt events.
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com.

Already have an account? Sign In Now
Join GlobeSt

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.